Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1204-1213

  Sauer, H ^a   Putz V ^a   Fischer, K ^a   Hescheler, J ^a   Wartenberg, M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Doxorubicin; Electrical field; Electrochemotherapy; Lipid diffusion; Lipid peroxidation; Multicellular tumour spheroid

Indexed keywords

4 HYDROXYNONENAL; DEHYDROASCORBIC ACID; DOXORUBICIN; FLUORESCEIN DIACETATE; HYDROGEN PEROXIDE; MALONALDEHYDE; MEMBRANE LIPID; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIRECT CURRENT; DRUG CYTOTOXICITY; DRUG UPTAKE; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; MEMBRANE DAMAGE; PRIORITY JOURNAL; TUMOR SPHEROID;

ANTINEOPLASTIC AGENTS; DIFFUSION; DOXORUBICIN; ELECTRIC STIMULATION; HUMANS; LIPID PEROXIDATION; MALE; MEMBRANE LIPIDS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0032988360     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690487     Document Type: Article

References (36)

1. Belehradek M, Domenge C, Luboinski B, Orowski S, Belehradek J Jr and Mir LM (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I II trial. Cancer 72: 3694-3700
2. Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B and Mir LM (1994) Electropermeabilization of cells in tissues assessed by qualitative electroloading of bleomycin. Biochim Biophys Acta 1190: 155-163
3. Benchekroun NM, Pourquier P, Schott B and Robert J (1993) Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin. Eur J Biochem 211: 141-146
4. Cameron IL, Hardman WE, Winters WD, Zimmerman S and Zimmerman AM (1993) Environmental magnetic fields: influences on early embryogenesis. J Cell Biochem 51: 417-425
5. Cummings J, Willmott N, Hoey BM, Marley ES and Smyth JF (1992) The consequences of doxorubicin quinone reduction in vivo in tumour tissue. Biochem Pharmacol 44: 2165-2174
6. de Wolf FA, Staffhorst RW, Smits HP, Onwezen MF and Kruijff B (1993) Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: drug binding and structural consequences in bacterial systems Biochemistry 32: 6688-6695
7. Deliconstantinos G, Villiotou V and Stavrides JC (1996) Tumour promotor tertbutyl-hydroperoxide induces peroxynitrite formation in human erythrocytes. Anticancer Res 16: 2969-2979
8. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr and Mir LM (1996) Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 77: 956-963
9. Frenkel K and Gleichauf C (1991) Hydrogen peroxide formation by cells treated with a tumour promotor. Free Rad Res Comms 12-13: 783-794
10. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS and Munoz-Hoyos A (1997) Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 26: 297-300
11. Germain E, Chajes V, Cognault S, Lhuillery C and Bougnoux P (1998) Enhancement of doxorubicin toxicity by polyunsaturated fatty acids in the human breast minor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 75: 578-583
12. Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS and Heller R (1996) Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 132: 1353-1357
13. Harrigan PR, Wong KF, Redelmeier TE, Wheeler JJ and Cullis PR (1993) Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta 1149: 329-338
14. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM and Reintgen DS (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous tumours using electrochemotherapy. Cancer 77: 964-971
15. Heller R, Jaroszeski M, Perrot R, Messina J and Gilbert R (1997) Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 7: 10-18
16. Hietanen P, Blomqvist C, Wasenius VM, Niskanen E, Frarnssila K and Nordling S (1995) Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer? Br J Cancer 71: 1029-1032
17. Keizer HG, Pinedo HM, Schuurhuist GJ and Joenje H (1990) Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmac Ther 47: 219-231
18. Koppel DE (1979) Fluorescence redistribution after photobleaching. Biophys J 28: 281-292
19. Mir LM, Devauchelle P, Quintin-Colonna F, Delisle F, Dolinger S, Fradelizi D, Belehradek J Jr and Orlowski S (1997) First clinical trial of cat son-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76: 1617-1622
20. Nishi T, Dev SB, Yoshizato K, Kuratsu J and Ushio Y (1997) Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes. Human Cell 10: 81-86
21. Olive PL and Durand RE (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastas Rev 13: 121-138
22. Poddevin B, Orlowski S, Belchradek J Jr and Mir LM (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42: S67-S75
23. Ramirez LH, Orlowski S, An D, Bindloula G, Dzodic R, Ardouin P, Bognet C, Belehradek J Jr, Munck J N and Mir LM (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77: 2104-2111
24. Remvikos Y, Mosseri V, Zajdela A, Fourquet A, Durand JC, Pouillard P and Magdelenat H (1993) Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy. Ann NY Acad Sci 698: 193-203
25. Rols M-P and Teissié (1990) Electropermeabilization of mammalian cells. Biophys J 58: 1089-1098
26. Sauer H, Hescheler J, Reis D, Diedershagen H, Niedermeier W and Wartenberg M (1997) DC electrical field-induced c-fos expression and growth stimulation in multicellular prostate cancer spheroids. Br J Cancer 75: 1481-1488
27. Sersa G, Cemazar M and Miklaveic D (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichlorophatinum (II) in mice. Cancer Res 55: 3450-3455
28. Speelmans G, Staffhorst RW, de Kruijff B and de Wolf FA (1994) Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry 33: 13761-13768
29. 51Cr release. Neurochem Res 20: 1417-1427
30. Susa N, Ueno S, Furukawa Y and Sugiyama M (1996) Protective effect of vitamin F, on chromium (VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. Arch Toxicol 71: 20-24
31. Verstraeten SV, Nogueira LV, Schreier S and Oteiza PI (1997) Effect of trivalent metal ions on phase separation and membrane lipid packing: role in lipid peroxidation. Arch Biochem Biophys 338: 121-127
32. 2+. Am J Physiol 272: R1677-R1683
33. Wartenberg M, Frey C, Diedershagen H, Ritgen J, Hescheler J and Sauer H (1998a) Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in qiuescent cell layers of large, multicellular prostate tumor spheroids. Int J Cancer 75: 855-863
34. Wartenberg M, Hescheler J, Acker H, Diedershagen H and Sauer H (1998b) Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the 'optical probe technique'. Cytometry 31: 137-145
35. Weaver JC (1993) Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 51: 426-435
36. Wedekind P, Kubilschek U, Heinrich O and Peters R (1996) Line-scanning microphotolysis for diffraction-limited measurements of lateral diffusion. Biophys J 71: 1621-1632